GE HealthCare
GEHC
1,105 hedge funds and large institutions have $25.1B invested in GE HealthCare in 2023 Q3 according to their latest regulatory filings, with 120 funds opening new positions, 409 increasing their positions, 369 reducing their positions, and 129 closing their positions.
17% more funds holding in top 10
Funds holding in top 10: 12 → 14 (+2)
11% more repeat investments, than reductions
Existing positions increased: 409 | Existing positions reduced: 369
0.99% more ownership
Funds ownership: 79.96% → 80.95% (+0.99%)
7% less first-time investments, than exits
New positions opened: 120 | Existing positions closed: 129
8% less call options, than puts
Call options by funds: $181M | Put options by funds: $196M
2% less funds holding
Funds holding: 1,133 → 1,105 (-28)
15% less capital invested
Capital invested by funds: $29.5B → $25.1B (-$4.46B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$414M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$188M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$152M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$120M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$88.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$256M |
| 2 |
Pzena Investment Management
New York
|
-$209M |
| 3 |
Jane Street
New York
|
-$184M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$144M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$106M |
GEHC Hedge Fund Activity: Q3 2023 in Review
1,105 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in GE HealthCare (GEHC) for Q3 2023, worth a combined $25.1B — down 15% from $29.5B a quarter earlier.
Sellers outnumbered buyers: 129 funds closed out of GEHC and 120 opened new positions — a net loss of 9 holders — while 369 trimmed existing stakes and 409 added.
The largest buyer was Vanguard Group, adding an estimated $414M. The largest seller was T. Rowe Price Associates, cutting an estimated $256M.
- 1,105 institutional investors held GE HealthCare (GEHC) as of Q3 2023, down from 1,133 in Q2 2023.
- Funds reported $25.1B of GE HealthCare stock for Q3 2023, down 15% quarter-over-quarter.
- 120 funds opened new GE HealthCare positions in Q3 2023 and 129 closed out, a net change of -9 holders.
- The largest GE HealthCare buyer in Q3 2023 was Vanguard Group, an estimated $414M added.
- The largest GE HealthCare seller in Q3 2023 was T. Rowe Price Associates, an estimated $256M sold.
Based on aggregated 13F filings for Q3 2023.